Evidence map›Paper›PMID 31827231›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Recurrent and novel USP6 fusions in cranial fasciitis identified by targeted RNA sequencing.

Vera A Paulson, Ivan A Stojanov, Jay K Wasman, Tamara Restrepo, Samantha Cano, Joanna Plunkitt, Sekhar Duraisamy, Marian H Harris, Deborah J Chute, Alyaa Al-Ibraheemi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 48 citations in OpenAlex.

  1. Orbital cranial fasciitis in childhood-a benign masquerader of rhabdomyosarcoma: case report and literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other PediatricJournal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Frontiers in oncology · 2022
    Article
  11. Atypical nodular fasciitis with a novel PAFAH1B1-USP6 fusion in a 22-month-old boy.Virchows Archiv : an international journal of pathology · 2021
    Article
  12. Nodular Fasciitis With Malignant Morphology and aInternational journal of surgical pathology · 2021
    Article
  13. Novel partners of USP6 gene in a spectrum of bone and soft tissue lesions.Virchows Archiv : an international journal of pathology · 2021
    Article
  14. Characterization of novel USP6 gene rearrangements in a subset of so-called cellular fibroma of tendon sheath.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  15. Review
  16. Fusion of the Lumican (Cancer genomics & proteomics
    Article
  17. Ubiquitin-specific Peptidase 6 (Cancer genomics & proteomics
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Vera A PaulsonDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Ivan A StojanovDepartment of Oral and Maxillofacial Medicine and Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Jay K WasmanDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Tamara RestrepoDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Samantha CanoDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0940-6627
Joanna PlunkittDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Sekhar DuraisamyDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Marian H HarrisDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Deborah J ChuteDepartment of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Alyaa Al-Ibraheemi *Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Alanna J Church *Department of Pathology, Boston Children's Hospital, Boston, MA, USA. Alanna.Church@childrens.harvard.edu.ORCID http://orcid.org/0000-0002-4835-5770
Boston Children's Hospital · USCase Western Reserve University · USCleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cranial fasciitis is a benign myofibroproliferative lesion of the scalp and underlying bones typically occurring in the pediatric population. Histologically, it is characterized by loose fascicles of stellate cells in a fibromyxoid background, findings similar to those described in the closely related variant nodular fasciitis. Previously characterized as a reactive process, the identification of USP6 translocations in over 90% of nodular fasciitis cases prompted their reclassification as a clonal neoplastic process. Unlike nodular fasciitis, the molecular underpinnings of cranial fasciitis are less clear. While a subset of cranial fasciitis has been associated with Wnt/β-catenin pathway dysregulation, recent case reports suggest that this entity may also harbor USP6 fusions, a finding we sought to further investigate. We identified fifteen archival cases of cranial fasciitis, five females and ten males ranging in age from 3 months to 9 years (median 11 months), composed of formalin-fixed paraffin-embedded and fresh frozen tissues (11 and 4 cases respectively). Samples were evaluated on an RNA-based targeted sequencing panel targeting genes recurrently rearranged in neoplasia, including USP6. Five of fifteen cases (33%) were positive for USP6 rearrangements predicted to result in the fusion of the entire USP6 coding region to the promoter of the 5' partner, (three of which were novel):  two SERPINH1-USP6 (novel) and one each of COL3A1-USP6 (novel), SPARC-USP6, and MYH9-USP6. These results demonstrate the recurrent nature of USP6 rearrangements in cranial fasciitis, and highlight the success of targeted RNA sequencing in identifying known and novel fusion partners. The identification of USP6 promoter-swapping rearrangements is helpful in understanding the underlying biology of cranial fasciitis, and reinforces its biologic relationship to nodular fasciitis. Targeted RNA sequencing is a helpful tool in diagnosing this pseudosarcomatous lesion.

Indexed as

ChildChild, PreschoolFasciitisFemaleHumansInfantMaleRecombinant Fusion ProteinsScalpSkullUbiquitin ThiolesteraseRecombinant Fusion ProteinsUbiquitin ThiolesteraseUSP6 protein, human

Identifiers

PMID31827231
OpenAlexW2995963156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.